These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 332179)

  • 1. Accumulation of tetracyclines by Escherichia coli K-12.
    Ball PR; Chopra I; Eccles SJ
    Biochem Biophys Res Commun; 1977 Aug; 77(4):1500-7. PubMed ID: 332179
    [No Abstract]   [Full Text] [Related]  

  • 2. Susceptibility of protein synthesis in Escherichia coli to tetracycline and minocycline.
    Chopra I; Shales S
    J Gen Microbiol; 1981 May; 124(1):187-9. PubMed ID: 7033463
    [No Abstract]   [Full Text] [Related]  

  • 3. Transport of the lipophilic analog minocycline differs from that of tetracycline in susceptible and resistant Escherichia coli strains.
    McMurry LM; Cullinane JC; Levy SB
    Antimicrob Agents Chemother; 1982 Nov; 22(5):791-9. PubMed ID: 6758689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptible Escherichia coli cells can actively excrete tetracyclines.
    McMurry LM; Aronson DA; Levy SB
    Antimicrob Agents Chemother; 1983 Oct; 24(4):544-51. PubMed ID: 6418064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of tetracycline and minocyclie transport in Escherichia Coli.
    Del Bene VE; Rogers M
    Antimicrob Agents Chemother; 1975 Jun; 7(6):801-6. PubMed ID: 1098571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport of tetracyclines through the bacterial cell membrane assayed by fluorescence: a study with susceptible and resistant strains of Staphylococcus aureus and Escherichia coli.
    Samra Z; Krausz-Steinmetz J; Sompolinsky D
    Microbios; 1978; 21(83):7-21. PubMed ID: 375035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmid-mediated tetracycline resistance in Escherichia coli involves increased efflux of the antibiotic.
    Ball PR; Shales SW; Chopra I
    Biochem Biophys Res Commun; 1980 Mar; 93(1):74-81. PubMed ID: 6990931
    [No Abstract]   [Full Text] [Related]  

  • 8. Transport of tetracyclines into Escherichia coli requires a carboxamide group at the C2 position of the molecule.
    Chopra I
    J Antimicrob Chemother; 1986 Dec; 18(6):661-6. PubMed ID: 3546242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activity in vitro and pharmacokinetics of minocycline (author's transl)].
    Simon C; Malerczyk V; Preuss I; Schmidt K; Grahmann H
    Arzneimittelforschung; 1976 Apr; 26(4):556-60. PubMed ID: 782466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for more than one mechanism of plasmid-determined tetracycline resistance in Escherichia coli.
    Shales SW; Chopra I; Ball PR
    J Gen Microbiol; 1980 Nov; 121(1):221-9. PubMed ID: 7019387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for broken minocycline by NMR and HPLC techniques: a new additional resistance mechanism mediated by tetB determinant.
    Jupeau-Vessières AN; Leroux YG; Scavizzi MR; el Manouni D; Gerbaud GR
    Res Microbiol; 1989; 140(3):207-19. PubMed ID: 2694246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal ion-tetracycline interactions in biological fluids. 2. Potentiometric study of magnesium complexes with tetracycline, oxytetracycline, doxycycline, and minocycline, and discussion of their possible influence on the bioavailability of these antibiotics in blood plasma.
    Berthon G; Brion M; Lambs L
    J Inorg Biochem; 1983 Aug; 19(1):1-18. PubMed ID: 6619838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovine pulmonary transit of tetracycline and minocycline.
    Cohen SH; Hoeprich PD; Gunther R; Merry JM; Franti CE
    Diagn Microbiol Infect Dis; 1987 Jan; 6(1):53-8. PubMed ID: 3802746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion of tetracycline across the outer membrane of Escherichia coli K-12: involvement of protein Ia.
    Chopra I; Eccles SJ
    Biochem Biophys Res Commun; 1978 Jul; 83(2):550-7. PubMed ID: 358984
    [No Abstract]   [Full Text] [Related]  

  • 15. Unique metabolic fate of a tetracycline (minocycline).
    Nelis HJ; de Leenheer AP
    Lancet; 1981 Oct; 2(8252):938. PubMed ID: 6117720
    [No Abstract]   [Full Text] [Related]  

  • 16. R-factor-mediated resistance to tetracycline in Escherichia coli K12: an R-factor with a mutation to temperature-sensitive tetracycline resistance.
    Young TW; Hubball SJ
    Biochem Biophys Res Commun; 1976 May; 70(1):117-24. PubMed ID: 776184
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bacteriological and clinical study of a new tetracycline, minocycline].
    Veyssier P; Boussougant Y; Mariel C
    Pathol Biol (Paris); 1973 Jan; 21(1):59-67. PubMed ID: 4570516
    [No Abstract]   [Full Text] [Related]  

  • 18. Minocycline.
    Jonas M; Cunha BA
    Ther Drug Monit; 1982; 4(2):137-45. PubMed ID: 7048646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of tetracyclines. I. Inhibition of cell division and protein and nucleic acid syntheses in Escherichia coli W.
    Miller GH; Khalil SA; Martin AN
    J Pharm Sci; 1971 Jan; 60(1):33-40. PubMed ID: 4994066
    [No Abstract]   [Full Text] [Related]  

  • 20. Tetracycline resistance determinants from groups A to D vary in their ability to confer decreased accumulation of tetracycline derivatives by Escherichia coli.
    Chopra I; Shales S; Ball P
    J Gen Microbiol; 1982 Apr; 128(4):689-92. PubMed ID: 6750037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.